๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Tacrolimus dosing in Chinese renal transplant recipients: a population-based pharmacogenetics study

โœ Scribed by Liang Li; Chuan-Jiang Li; Lei Zheng; Yan-Jun Zhang; Hai-Xia Jiang; Bo Si-Tu; Zhong-Hai Li

Publisher
Springer
Year
2011
Tongue
English
Weight
170 KB
Volume
67
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Tacrolimus dose requirement in relation
Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients
โœ Wang Wei-lin; Jin Jing; Zheng Shu-sen; Wu Li-hua; Liang Ting-bo; Yu Song-feng; Y ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB

The aim of this study was to investigate whether the heterogeneity in tacrolimus dose requirement is associated with ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients during the first month after transplantation. ABCB1 and CYP3A5 genotyping was performed using the polymerase c

Evaluation of renal function in liver tr
Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial
โœ Eric M. Yoshida; Paul J. Marotta; Paul D. Greig; Norman M. Kneteman; Denis Marle ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 111 KB

Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation. We report a randomized clinical trial comparing daclizumab, delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6), Investigational Arm (n